The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chumovatov N.V.

Central Tuberculosis Research Institute

Sakharova G.M.

Central Tuberculosis Research Institute;
Russian Research Institute of Health

Antonov N.S.

Central Tuberculosis Research Institute;
Russian Research Institute of Health

Komissarova O.G.

Central Research Institute of Tuberculosis;
N.I. Pirogov Russian National Research Medical University

Chernyh N.A.

Central Tuberculosis Research Institute

Romanov V.V.

Central Tuberculosis Research Institute

Post-tuberculosis pulmonary health: a vital healthcare problem

Authors:

Chumovatov N.V., Sakharova G.M., Antonov N.S., Komissarova O.G., Chernyh N.A., Romanov V.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(11): 100‑105

Read: 462 times


To cite this article:

Chumovatov NV, Sakharova GM, Antonov NS, Komissarova OG, Chernyh NA, Romanov VV. Post-tuberculosis pulmonary health: a vital healthcare problem. Russian Journal of Preventive Medicine. 2025;28(11):100‑105. (In Russ.)
https://doi.org/10.17116/profmed202528111100

Recommended articles:

References:

  1. Visca D, Centis R, Munoz-Torrico M, et al. Post-tuberculosis sequelae: the need to look beyond treatment outcome. International Journal of Tuberculosis and Lung Diseases. 2020;24(8):761-762.  https://doi.org/10.5588/ijtld.20.0488
  2. Khan R, Malik NI, Razaque A. Imaging of Pulmonary Post-Tuberculosis Sequelae. Pakistan Journal of Medical Sciences. 2020;36(1):75-82.  https://doi.org/10.12669/pjms.36.ICON-Suppl.1722
  3. Allwood BW, Byrne A, Meghji J, et al. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration. 2021; 100(8):751-763.  https://doi.org/10.1159/000512531
  4. Pontali E, Silva DR, Marx FM, et al. Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs. Archivos de Bronconeumología. 2022; 58(11):754-763.  https://doi.org/10.1016/j.arbres.2022.05.010
  5. Ranzani OT, Rodrigues LC, Bombarda S, et al. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study. Lancet Infections Diseases. 2020;20(1):123-132.  https://doi.org/10.1016/S1473-3099(19)30518-3
  6. Amaral AF, Coton S, Kato B, et al. BOLD Collaborative Research Group. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. European Respiratory Journal. 2015;46(4):1104-1112. https://doi.org/10.1183/13993003.02325-2014
  7. Choi H, Han K, Jung JH, et al. Long-Term Mortality of Tuberculosis Survivors in Korea: A Population-based Longitudinal Study. Clinical Infectious Diseases. 2023;76(3):973-981.  https://doi.org/10.1093/cid/ciac411
  8. Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020;75(3):269-278.  https://doi.org/10.1136/thoraxjnl-2019-213808
  9. Xing Z, Sun T, Janssens JP, et al. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey. Thorax. 2023;78(3):274-280.  https://doi.org/10.1136/thoraxjnl-2021-218345
  10. Nightingale R, Chinoko B, Lesosky M, et al. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study. Thorax. 2022;77(11):1131-1139. https://doi.org/10.1136/thoraxjnl-2021-217190
  11. Sotgiu G, Centis R, Migliori GB. Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating. Lancet Global Health. 2021; 9(12):1628-1629. https://doi.org/10.1016/S2214-109X(21)00454-X
  12. Akalu TY, Clements ACA, Liyew AM, et al. Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis. EClinicalMedicine. 2024;77:102898. https://doi.org/10.1016/j.eclinm.2024.102898
  13. Chen HY, Lai SW, Muo CH, et al. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. British Journal of Ophthalmology. 2012;96(11):1368-1371. https://doi.org/10.1136/bjophthalmol-2012-301870
  14. Verma R, Sarkar S, Garg RK, et al. Ophthalmological manifestation in patients of tuberculous meningitis. QJM. 2019;112(6):409-419.  https://doi.org/10.1093/qjmed/hcz037
  15. Jin KW, Lee JY, Rhiu S, et al. Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy. PLoS One. 2019;14(4):0215297. https://doi.org/10.1371/journal.pone.0215297
  16. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine. 2001; 163(6):1376-1383. https://doi.org/10.1164/ajrccm.163.6.2004035
  17. Shah M, Reed C. Complications of tuberculosis. Current Opinion in Infectious Diseases. 2014;27(5):403-410.  https://doi.org/10.1097/QCO.0000000000000090
  18. Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86(1):76-85.  https://doi.org/10.1159/000350917
  19. Seo W, Kim HW, Kim JS, et al. Long term management of people with post-tuberculosis lung disease. Korean Journal Internal Medicine. 2024;39(1):7-24.  https://doi.org/10.3904/kjim.2023.395
  20. Bilton D. Update on non-cystic fibrosis bronchiectasis. Current Opinion in Pulmonary Medicine. 2008;14(6):595-599.  https://doi.org/10.1097/MCP.0b013e328312ed8c
  21. Ko JM, Kim KJ, Park SH, et al. Bronchiectasis in active tuberculosis. Acta Radiologica. 2013;54(4):412-417.  https://doi.org/10.1177/0284185113475796
  22. Buscot M, Pottier H, Marquette CH, et al. Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis: A 10-Year Cohort Study in a French Regional University Hospital Center. Respiration. 2016;92(1):1-8.  https://doi.org/10.1159/000446923
  23. Seo H, Cha SI, Park J, et al. Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea. Journal of Thoracic Diseases. 2023;15(7):3636-3645. https://doi.org/10.21037/jtd-22-1541
  24. Lee JH, Park SS, Lee DH, et al. Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases. Chest. 1992;102(4):990-994.  https://doi.org/10.1378/chest.102.4.990
  25. Malikova OG, Komissarova OG, Chumovatov NV, Ergeshov AE. Pulmonary tuberculosis complicated by tuberculosis of the tracheobronchial tree. Vestnik Central’nogo nauchno-issledovatel’skogo instituta tuberkuleza. 2023; 4:12-22. (In Russ.). https://doi.org/10.57014/2587-6678-2023-7-4-12-22
  26. Benator D, Bhattacharya M, Bozeman L, et al. Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360(9332): 528-534.  https://doi.org/10.1016/s0140-6736(02)09742-8
  27. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270-277.  https://doi.org/10.1136/thoraxjnl-2014-206291

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.